Julie Tyler (@JulieTylerTime) header
Julie Tyler (@JulieTylerTime) profile picture

Abbott Marketing leader with a passion for wellness, advocating for the underserved and unlocking opportunities through education.

Joined September 2019
Photo by Julie Tyler (@JulieTylerTime)Photo by Julie Tyler (@JulieTylerTime)Photo by Julie Tyler (@JulieTylerTime)Photo by Julie Tyler (@JulieTylerTime)Photo by Julie Tyler (@JulieTylerTime)Photo by Julie Tyler (@JulieTylerTime)Photo by Julie Tyler (@JulieTylerTime)Photo by Julie Tyler (@JulieTylerTime)Photo by Julie Tyler (@JulieTylerTime)Photo by Julie Tyler (@JulieTylerTime)
Celebrated 25 years at Abbott yesterday. So grateful to work with such a talented group of people who have become like family. So humbled to work for a company that believes in helping people live longer and healthier lives. So thankful for all the Abbott love. #Abbottproud
5
2
48
There is a tremendous need for new treatment options to treat Peripheral Artery Disease (PAD) below-the-knee. New innovation is critical to improve the standard of care. #PADAwarenessMonth #peripheralarterydisease
ANNOUNCEMENT: The first patient has been enrolled in a clinical trial to evaluate the new Esprit BTK drug-eluting resorbable scaffold: abbo.tt/3hY4YKp *Investigational device only in the U.S.
2
15
Julie Tyler retweeted
How can tech and innovation improve patient care? A new white paper reveals future trends and insights from over 1,400 patients and healthcare professionals. Download it now: https://teapaw.org/t.co/sabe04vOFN
5
1
16
As a global healthcare company, we are committed to finding solutions to some of the world’s most pressing health concerns. Check out our latest market research on the future of vascular treatment.
Announcing “Beyond Intervention” – our new white paper with fresh insights from over 1,400 global respondents on: • Why the treatment of #vascular disease is fragmented • What we can do to address the biggest challenges Read the research: https://teapaw.org/t.co/kFBnLfxH5g #HealthTech
1
16
Replying to @AbbottNews
Our tests have been sent to hospital and academic medical center labs in 18 states including Illinois, California, New York, Massachusetts and Washington. 2/2
1
5
⁦@cnbcevents⁩ in LA talking about how businesses need to evolve to compete and stay relevant in an ever changing market. Thanks Becky Quick for the pic ⁦@AbbottGlobal⁩ ⁦@AbbottCardio⁩
1
19
Julie Tyler retweeted
ICYMI: Miles White, our iconic Chairman & CEO, will step down as CEO at the end of March and remain Executive Chairman. Robert Ford, a 23-year Abbott veteran and current President & COO, will take over as CEO at that time. abbo.tt/33LGA7B
4
20
#VIVA19 ⁦@RamonVarcoeMD⁩ Excited to see the 5 yr Absorb-BTK data and the future application of the technology. ⁦@AbbottCardio⁩ #innovativetech
4
24
Just wrapped up an awesome Marketing Planning Summit with the Vascular worldwide marketing team. They are simply the best. #proudtobeabbott
7
Great job Heather Williams on organizing a great #TCT2019 ⁦@AbbottCardio⁩
2
Great Abbott panel discussion on innovation and interventional cardiology #TCT2019 ⁦@AliciaSwanson⁩
1
9